Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY4 | P51582 | 12/20 | 0.62 |
| ▸ | GNG2 | P59768 | 5/20 | 0.62 |
| ▸ | GNB1 | P62873 | 5/20 | 0.62 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.59 |
| ▸ | MET | P08581 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | P2RY2 | P41231 | 6/20 | 0.54 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.52 |
| ▸ | HPGDS | O60760 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL792734 | 0.89 | P2RY4 (0.80) | P2RY4METP2RY2P2RY12 | |
| SCHEMBL790883 | 0.87 | GNG2 (0.66) | P2RY4GNG2GNB1PHLPP2MET | |
| SCHEMBL790997 | 0.87 | GNG2 (0.67) | P2RY4GNG2GNB1PHLPP2MET | |
| SCHEMBL788754 | 0.86 | P2RY4 (0.67) | P2RY4GNG2GNB1PHLPP2MET | |
| SCHEMBL15371416 | 0.86 | GNG2 (0.67) | P2RY4GNG2GNB1PHLPP2MET | |
| SCHEMBL10776142 | 0.86 | GNG2 (0.69) | P2RY4GNG2GNB1PHLPP2MET | |
| SCHEMBL791053 | 0.85 | GNG2 (0.65) | P2RY4GNG2GNB1PHLPP2MET | |
| SCHEMBL15371404 | 0.85 | P2RY4 (0.69) | P2RY4GNG2GNB1PHLPP2MET | |
| SCHEMBL15371415 | 0.84 | GNG2 (0.66) | P2RY4GNG2GNB1PHLPP2MET | |
| SCHEMBL790527 | 0.84 | P2RY4 (0.58) | P2RY4GNG2GNB1PHLPP2MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616449-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | Dundalk Institute of Technology (IE) | 2013-07-24 | — | — | EP | claimed |
| WO-2012035122-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2012-03-22 | — | — | WO | claimed |
| US-9877940-B2 | Anthraquinone compounds and their uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2018-01-30 | — | — | US | disclosed |
| US-20160243066-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2016-08-25 | — | — | US | disclosed |
| US-20130296588-A1 | Anthraquinone Compounds and Their Uses | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2013-11-07 | — | — | US | disclosed |
| EP-2616449-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | Dundalk Institute of Technology (IE) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012035122-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | DUNDALK INSTITUTE OF TECHNOLOGY (IE) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296588-A1 | Anthraquinone Compounds and Their Uses | MYLK, CYP11B2, MYOC | P2RY4 1539/4885GNG2 342/4885GNB1 159/4885 |
| US-20160243066-A1 | ANTHRAQUINONE COMPOUNDS AND THEIR USES | MYLK, MYLK2, MYH10 | P2RY4 1744/4885GNG2 345/4885GNB1 201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.